WIPO trademark

Aujemflu Adjuvanted Cell-based Trivalent Influenza Vaccine

MixedWIPOClass 5

"Aujemflu Adjuvanted Cell-based Trivalent Influenza Vaccine" is a trademark owned by Seqirus Inc., filed at the WIPO on October 31, 2025. It is on file and covers class 5 (Pharmaceuticals).

View Seqirus Inc. portfolioGet this data via the API
Aujemflu Adjuvanted Cell-based Trivalent Influenza Vaccine
Trademark as filed with the WIPO
Status
Mixed
Filed
October 31, 2025
Registered
Not yet
Expires
October 31, 2035
Application no.
Not recorded
Registration no.
1892970
Office
WIPO
World Intellectual Property Organization
Mark type
Trademark
1 class
Ownership

Who owns Aujemflu Adjuvanted Cell-based Trivalent Influenza Vaccine

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Seqirus Inc.

United States

231 trademarks in the portfolioView company

Representative

Gowling WLG (Canada) LLP

Gowling WLG (Canada) LLP

Goods and services

What the mark covers

The products and services Aujemflu Adjuvanted Cell-based Trivalent Influenza Vaccine is filed for, grouped by Nice class.

FAQ

About Aujemflu Adjuvanted Cell-based Trivalent Influenza Vaccine

Who owns the trademark "Aujemflu Adjuvanted Cell-based Trivalent Influenza Vaccine"?

The WIPO trademark "Aujemflu Adjuvanted Cell-based Trivalent Influenza Vaccine" is owned by Seqirus Inc.

What is the status of "Aujemflu Adjuvanted Cell-based Trivalent Influenza Vaccine"?

Its status at the WIPO is: mixed.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull Aujemflu Adjuvanted Cell-based Trivalent Influenza Vaccine and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_bc287071-328d-4a8c-848d-e4cc84a6bdb2
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_bc287071-328d-4a8c-848d-e4cc84a6bdb2",
  "object": "trademark",
  "mark_text": "Aujemflu Adjuvanted Cell-based Trivalent Influenza Vaccine",
  "status": {
    "primary": "mixed",
    "stage": "mixed"
  },
  "office_code": "WO",
  "application_number": null,
  "filing_date": "2025-10-31",
  "nice_classes": [
    5
  ],
  "owners": [
    {
      "name": "Seqirus Inc.",
      "entity_id": "ent_019eb7d7-073e-746b-967e-2a965cfa764c"
    }
  ]
}